Clinical trial

Effects and Safety of Different Dose of Bambuterol on Chinese COPD Patients

NCT01796730

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2013-02-01

PhasePHASE4

Study timeline

Study start (unknown)2013-02-01Date precision: month

Registry last updated2015-03-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPDunresolved

Interventions

bambuterolDRUG

PlaceboDRUG

Sponsors & collaborators

The First Affiliated Hospital of Guangzhou Medical Universitylead sponsor

Nanfang Hospital, Southern Medical Universitycollaborator

Guangzhou First People's Hospitalcollaborator

Mapped research locations

GuangzhouGuangdong, China3

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT01796730 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.